Method for predicting susceptibility of coronary heart disease and kit thereof
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- TONGJI HOSPITAL ATTACHED TO TONGJI MEDICAL COLLEGE HUAZHONG SCI TECH
- Publication Date
- 2011-08-17
- Estimated Expiration
- Not applicable · inactive patent
Smart Images
Figure 1 Figure 2 Figure 3
Abstract
Description
technical field
[0001] The present invention relates to a method for predicting the susceptibility of coronary heart disease (coronary artery disease, CAD), specifically by measuring human dimethylarginine dimethylamine hydrolase 1 (DDAH1) gene polymorphism site -396D / I is used to predict the susceptibility of the population to coronary heart disease. This method can be used for auxiliary diagnosis, treatment, and new drug development of diseases, and belongs to the field of medical biotechnology and genetic diagnosis. Background technique
[0002] In recent years, the morbidity and mortality of coronary heart disease in my country have been rising rapidly, and it has become an important disease that has risen the fastest among the causes of death among Chinese residents and threatens the public health of our country. Traditional risk factors such as hypertension, diabetes, overweight and obesity, smoking and drinking, hyperlipidemia, etc. can cause atherosclerosis, but man...